Effect of mycophenolate mofetil alleviates carbon tetrachloride-induced liver fibrosis in mice.
10.11817/j.issn.1672-7347.2023.220542
- Author:
Peng DING
1
;
Pengpeng ZHANG
2
;
Hao LI
3
;
Yingzi MING
4
Author Information
1. Organ Transplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013. 491825729@qq.com.
2. Organ Transplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013. zpp_china@163.com.
3. Organ Transplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013.
4. Organ Transplantation Center, Third Xiangya Hospital, Central South University, Changsha 410013. myz_china@aliyun.com.
- Publication Type:Journal Article
- Keywords:
collagen I;
hepatic fibrosis;
mycophenolate mofetil;
transforming growth factor-β1;
α-smooth muscle actin
- MeSH:
Male;
Animals;
Mice;
Mice, Inbred C57BL;
Mycophenolic Acid/therapeutic use*;
Carbon Tetrachloride/toxicity*;
Transforming Growth Factor beta1/genetics*;
Liver Cirrhosis/drug therapy*;
RNA, Messenger
- From:
Journal of Central South University(Medical Sciences)
2023;48(6):821-828
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Hepatic fibrosis is a serious pathological consequence of chronic liver disease. Mycophenolate mofetil (MMF) is a commonly used immunosuppressant after organ transplant. However, the relationship between MMF and hepatic fibrosis remains unclear. This study aims to explore the effect of MMF on hepatic fibrosis in mice and the potential mechanism.
METHODS:A total of 24 mice (male, 8-week old, C57BL/6) were randomly divided into a control group, a MMF group, a carbon tetrachloride (CCl4) group and a CCl4+MMF group (n=6 in each group). After the mice were sacrificed, the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were detected. The liver tissues were taken up for Masson staining and collagen I (COL1) immunohistochemistry. The levels of transforming growth factor-β1 (TGF-β1) and α-smooth muscle actin (α-SMA) were detected by Western blotting. Finally, the levels of mRNA for TGF-β1, α-SMA, and COL1 were detected using real-time PCR.
RESULTS:Compared with the CCl4 group, the ALT and AST levels were lower (both P<0.05), the degree of liver fibrosis was alleviated, and the deposition of COL1 in the liver was significantly decreased (P<0.01) in the CCl4+MMF group. Compared with the CCl4 group, the protein expression levels of TGF-β1 and α-SMA were significantly decreased (both P<0.05) and the relative expression levels of TGF-β1, α-SMA and COL1 mRNA in the liver were significantly decreased (all P<0.05) in the CCl4+MMF.
CONCLUSIONS:MMF could reduce CCl4-induced hepatic fibrosis, which might be related to the inhibition of TGF-β1. This study is expected to provide a target for the treatment of hepatic fibrosis.
